WF
SZYM

Welch & Forbes’s SOLAZYME INC COM STK (DE) SZYM Stock Holding History

Welch & Forbes’s Portfolio SZYM Stock Details SZYM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q2 		– Sell
-51,600
Closed -$105K – 357
2016
Q1 		$105K Sell
51,600
-34,150
-40% -$60.9K ﹤0.01% 336
2015
Q4 		$212K Sell
85,750
-3,000
-3% -$8.9K 0.01% 308
2015
Q3 		$230K Buy
88,750
+1,500
+2% +$3.91K 0.01% 310
2015
Q2 		$274K Buy
87,250
+4,100
+5% +$14.1K 0.01% 294
2015
Q1 		$238K Buy
83,150
+7,500
+10% +$19.2K 0.01% 306
2014
Q4 		$195K Sell
75,650
-918,003
-92% -$4.02M 0.01% 335
2014
Q3 		$7.41M Buy
993,653
+40,872
+4% +$382K 0.23% 100
2014
Q2 		$11.2M Buy
952,781
+64,685
+7% +$690K 0.35% 80
2014
Q1 		$10.3M Buy
888,096
+181,311
+26% +$2.13M 0.33% 85
2013
Q4 		$7.7M Buy
706,785
+261,215
+59% +$2.57M 0.24% 99
2013
Q3 		$4.81M Buy
445,570
+16,700
+4% +$190K 0.16% 119
2013
Q2 		$5.03M Buy
+428,870
New +$4.28M 0.18% 111

Welch & Forbes's SZYM Position: Q2 2016 in Review

Welch & Forbes sold out of SOLAZYME INC COM STK (DE) (SZYM) in Q2 2016, closing a stake of 51,600 shares — an estimated $105K sold.

Welch & Forbes first reported a position in SZYM in Q2 2013 and held it in 12 quarters. The position peaked at $11.2M in Q2 2014. 0 funds tracked by Wall St. Rank hold SZYM as of Q2 2016.

  • Welch & Forbes reported no remaining SOLAZYME INC COM STK (DE) position as of Q2 2016 after selling out during the quarter.
  • Welch & Forbes sold 51,600 SOLAZYME INC COM STK (DE) shares in Q2 2016, an estimated $105K.
  • Welch & Forbes first reported a position in SOLAZYME INC COM STK (DE) in Q2 2013 and held it in 12 quarters.
  • Welch & Forbes's SOLAZYME INC COM STK (DE) position peaked at $11.2M in Q2 2014.
  • 0 funds tracked by Wall St. Rank held SOLAZYME INC COM STK (DE) as of Q2 2016.

Based on Welch & Forbes's 13F filing for Q2 2016, filed 2 Aug 2016.